Day: September 1, 2021
Verizon Frontline is the advanced network and technology built for first responders, developed over three decades of partnership with the public safety community.
The Verizon Response Team has deployed more than 300 Verizon Frontline solutions to support more than 35 public sector agencies conducting emergency response operations in Southeastern Louisiana.HAMMOND, La., Sept. 01, 2021 (GLOBE NEWSWIRE) — The Verizon Response Team arrived in Southeastern Louisiana Monday to deliver Verizon Frontline technology to first responders conducting search and rescue and disaster response operations in some of the areas hardest hit by Hurricane Ida.
The Verizon Response Team was activated last week and pre-positioned just outside of the expected storm track, enabling a rapid response effort when conditions permitted and allowing the team...
SomaLogic Closes Business Combination and Will Begin Trading Under the Ticker “SLGC” on the Nasdaq Stock Exchange
Written by Customer Service on . Posted in Mergers And Acquisitions.
SomaLogic to debut on Nasdaq as a leading publicly traded AI-data driven proteomics platform company
Business combination results in approximately $630 million in gross cash proceeds to catalyze organic and inorganic growth initiatives
Combined company to trade on Nasdaq under ticker “SLGC”NEW YORK and BOULDER, Colo., Sept. 01, 2021 (GLOBE NEWSWIRE) — SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced that it has completed its business combination with CM Life Sciences II, Inc. (Nasdaq: CMIIU), a special purpose acquisition company sponsored by affiliates of leading healthcare and life sciences fund advisors Casdin Capital and Corvex Management. Following the transaction, the combined company was renamed SomaLogic, Inc., and its Class A common stock and warrants will begin trading on the Nasdaq...
Number of voting rights as of August 31, 2021
Written by Customer Service on . Posted in Public Companies.
Nicox SA
Société anonyme with a registered capital of € 37,125,385
Head Office:
DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis
R.C.S. GRASSE 403.942.642
On September 1, 2021,
MONTHLY PUBLICATION OF THE NUMBER OF SHARES COMPOSING THE SHARE CAPITAL AND OF THE TOTAL NUMBER OF VOTING RIGHTS
(Article L.233-8 II of the Code de Commerce and Articles 221-1 and 223-16 of the Règlement général of the l’AMF)
As of August 31, 2021Total number of shares composing the share capital
37,125,385Total number of voting rights
37,125,385Total number of voting rights, calculated based on the total number of shares, including the shares deprived of voting rights
37,125,385
—————
www.nicox.com
Phone: +33 4-97-24-53-00
Fax : +33 4-97-24-53-99
Attachment31 aout...
Sýn hf.: Growth in telecommunication and media
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Sýn hf.‘s Condensed Consolidated Interim Financial Statement for the first half of 2021 was approved by the board of directors on September 1st 2021.
Main results: • Revenue for the second quarter (Q2) of 2021 amounted to ISK 5,289M, a decrease of ISK 98M compared to the same period in 2020. Revenue for the first half (1H) of 2021 amounted to ISK 10,289M, a decrease of 1.2% compared to 1H 2020. This decrease can mainly be traced to a 650M decrease in revenues of Endor.
• EBITDA for Q2 2021 amounted to ISK 1,488M, compared to ISK 1,364M in Q2 2020. The EBITDA margin was 28.1% in Q2 2021 compared to 25.3% in Q2 2020. EBITDA for 1H 2021 amounted to ISK 2,876M, a 5.8% increase compared to the same period in 2020.
• Loss in Q2 2021 amounted to ISK 117M compared to ISK 60M in Q2 2020. Loss for 1H 2021 amounted to ISK 348M compared to ISK...
Valneva to Participate in Goldman Sachs Eleventh Annual Biotech Symposium
Written by Customer Service on . Posted in Public Companies.
Saint-Herblain (France), September 1, 2021 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that its senior management will participate in 1-on-1 meetings with institutional investors at the Goldman Sachs Eleventh Annual Biotech Symposium on September 7, 2021.
Valneva’s Chief Executive Officer Thomas Lingelbach and acting Chief Financial Officer David Lawrence will notably provide an update on the Company’s late stage vaccine candidates against Lyme disease (VLA15), COVID-19 (VLA2001) and chikungunya (VLA1553).
Partnered with Pfizer (NYSE: PFE), VLA15 is the only Lyme disease vaccine in clinical development worldwide while VLA2001 is the only inactivated vaccine candidate in clinical trials against COVID-19 in Europe and VLA1553 is the only single-shot chikungunya vaccine candidate in Phase...
ONCOTELIC TO ACQUIRE LATE-STAGE DRUG CANDIDATE FOR PARKINSON DISEASE, ERECTILE DYSFUNCTION, AND FEMALE SEXUAL DYSFUNCTION.
Written by Customer Service on . Posted in Public Companies.
AGOURA HILLS, Calif., Sept. 01, 2021 (GLOBE NEWSWIRE) — Oncotelic Therapeutics, Inc. (“Oncotelic” or the “Company”) (OTCQB:OTLC), executed a binding term sheet with Autotelic Inc. to license AL-101 (intranasal apomorphine). Oncotelic intends to develop AL-101 via fast-to-market 505(b)2 regulatory pathway for Parkinson Disease (“PD”) and Erectile Dysfunction (“ED”), especially phosphodiesterase 5 (“PDE5”) non-responders. AL-101 will also be developed as a new drug against Female Sexual Dysfunction (“FSD”), including Hypoactive Sexual Desire Disorder (“HSDD”). AL-101 has a favorable safety and efficacy profile and is phase 3 ready with six clinical trials completed and over 200 patients (2,200 doses) treated.
“The acquisition of AL-101, expands Oncotelic’s product portfolio to the fast to market 505(b)2...
OSE Immunotherapeutics to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
Written by Customer Service on . Posted in Public Companies.
September 13 – 15, 2021 (Virtual Conference)
NANTES, France, Sept. 01, 2021 (GLOBE NEWSWIRE) — OSE Immunotherapeutics (ISIN: FR0012127173) today announced it will present at the H.C. Wainwright 23rd Annual Global Investment Conference. The conference is being held virtually on September 13 – 15, 2021.
Alexis Peyroles, CEO of OSE Immunotherapeutics, will provide an overview of the Company’s business during the live presentation and will be available to participate in one-on-one meetings with investors who are registered to attend the conference.
If you are an institutional investor and would like to attend the Company’s presentation, please click on the following link to register for the conference: www.hcwevents.com. Once your registration is confirmed, you will be prompted to log into the conference website to request...
Delta Drone : The development strategy in the Southern Hemisphere, carried by Delta Drone International, is set up
Written by Customer Service on . Posted in Mergers And Acquisitions.
The development strategy in the Southern Hemisphere,carried by Delta Drone International, is set up
Dardilly, September 1, 2021 – 6 p.m.
Key points:Delta Drone International’s consolidated revenue for the first half of 2021 was MAU$ 2.49 million ($1.6 million), up +53.3%,
Geographical expansion continues, with the signing of new contracts in Namibia and Zambia,
The range of services is completed: solution based on Lidar technology, security solution and development of the training center in South Africa,
The definitive signing of the acquisition of Arvista Pty Ltd, a company based in Perth (Western Australia), will make it possible to duplicate Rocketmine’s business model in Australia.
Delta Drone has strengthened its stake in its subsidiary and now holds 53.1% of the capital.Delta Drone International, an Australian...
Bureau Veritas acquires AET France, a company specializing in laboratory testing, product development and sustainability testing
Written by Customer Service on . Posted in Mergers And Acquisitions.
PRESS RELEASE
Neuilly-sur-Seine, France – September 1, 2021
Bureau Veritas acquires AET France, a company specializing in laboratory testing, product development and sustainability testing
This acquisition reinforces BV position in the European consumer goods retail market
Bureau Veritas, a world leader in testing, inspection and certification, announces the acquisition of AET France, a France-based testing company providing product development, project management, and user experience testing services for consumer goods markets.
AET France, founded in 2010, has 25 employees and posted revenues of €2 million in 2020.
The company serves start-ups as well as large companies worldwide, by offering a suite of innovative solutions:Laboratory Testing beyond compliance: AET France specializes in consumer experience testing with a strong understanding...
Moye White Expands to Georgia Adds Office in Atlanta
Written by Customer Service on . Posted in Mergers And Acquisitions.
The Firm Welcomes Trusted Counsel to the Firm
DENVER, Sept. 01, 2021 (GLOBE NEWSWIRE) — Moye White LLP is pleased to announce the opening of a new office in Atlanta, Georgia, the first expansion outside Colorado in the firm’s 45-year history. The firm has also welcomed four new attorneys and team members to its Business Section as it merged with Trusted Counsel (Ashley) LLC, a corporate and intellectual property boutique law firm.
“This merger reinforces our commitment to serving our national and regional clients with the same high standards of service, excellence, and care that we have developed while operating in Colorado since 1976,” said Managing Partner Thomas M. List. “Over the years, our client base has expanded, as have the needs of our clients. This will position us to best represent our clients with significant operations...